News
Our latest news
Blood Plasma Microsampling for a Person-Centric Diagnostic Solution
Blog | september 2024
Dried blood spot (DBS) testing is used for the analysis of many molecules associated with human health and disease, with maj […]
An Introduction to Decentralised Clinical Trials
Decentralised clinical trials gained momentum during the COVID-19 pandemic, and their prevalence continues to grow rapidly. […]
Publication highlight: Swedish study demonstrates compatibility of Capitainer self-sampling with Olink’s proteomics for large-scale health studies
Blog | augusti 2024
To gain new insights about the long-term impact of SARS-CoV-2 infection, researchers in Sweden used a Capitainer self-sampli […]
Mathias Karlsson elected to Labquality’s board to promote quality in healthcare globally
Press release | juli 2024
Capitainer is proud to announce that Mathias Karlsson, Chief Medical Officer at Capitainer, has been elected to the board of […]
Major kidney study involving Capitainer featured in Scandinavian healthcare magazines
News | juni 2024
Capitainer is proud to see its blood self-sampling technology featured in leading healthcare publications in Sweden, Norway, […]
An Introduction to Multiplex Proteomics
Blog | juni 2024
Multiplex proteomics allows researchers to analyse proteins in two or more different sample preparations simultaneously. Whe […]
Large study for individually adapted dietary advice carried out by self-sampling with Capitainer
Press release | juni 2024
Chalmers University of Technology is currently conducting SCAPIS2-HOME, a groundbreaking study in precision nutrition. The g […]
Capitainer Enters African Market through Strategic Partnership with Lasec®
Capitainer, a leading Swedish medtech company specializing in advanced self-sampling solutions, has entered into a distribut […]
Proteomics study with Capitainer featured in two articles
News | maj 2024
Capitainer is proud to be featured in two recent articles; one article by GenomeWeb, entitled Swedish Researchers Use Olink […]
